Personalized Medicines: Are They Worth It?
Are personalized medicines and companion diagnostics actually enhancing the drug development process? Or should we share the concerns of some stakeholders that blockbusters are to be replaced by a new era of ‘nichebusters’? ...Read more |
Nanotech: Big Stakes in Small Things
Nanomedicines — drugs, devices and research tools that apply the principles of nanotechnology — may offer patients a better clinical outcome than regular drug therapy, but their future depends on resolving issues that the familiar Big Pharma business model has been slow to address ... Read more
|
Seeing Beyond the Big Data Backlash
Is ‘Big Data’ just a load of hype? The recent backlash suggests it might be. But Peter Houston looks beyond the buzzwords to reveal what companies should be focusing on ... Read more
|
US Pharma and ‘Obamacare’: Two Months In
Tom Norton speaks to US drug reps on their experience with Obamacare, as well as their thoughts on how it is impacting their marketing, sales, and R&D planning for 2014 and beyond ... Read more
|
Pharm Exec Global Digest: Personalized Medicine Special
Personalized medicines: Are they worth it?; Pathology in the era of personalized medicine; Clinical trial data disclosure — has Europe bitten off more than it can chew?; China: recruiting amid the corruption fallout; And more! ... Read more
|
|
|
PHT Corporation |
 How to Implement an ePRO Strategy; A FREE Best Practices Guide. Four pharma patient reported outcome (PRO) experts explain how to implement and leverage the efficiencies of an ePRO strategy.  Read the complimentary eBook here |
|
|
|
|
|
| Sciformix |
 Product labeling– Increasing efficiency, enhancing quality, and delivering compliance
Pharmaceutical product labeling is a highly regulated and complex process. A product label is very specific in its content, with respect to safety data, adverse effects and compliance to country specific regulations.  Read more. |
|
|
|
|
|
|
